Chennai Meenakshi Multispeciality Hospital Ltd.
Snapshot View

13.29 +0.43 ▲3.3%

05 August 2021, 04:00:00 P.M.
Volume: 850

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.cmmh.in
Financial Indicators
Market Cap 9.61 Cr.
Earnings per share (EPS) -1.67 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 202.10 Trailing Twelve Months Ending 2021-03
Book Value / Share -6.44 Trailing Twelve Months Ending 2021-03
Price to Book Value -2.00 Calculated using Price: 12.86
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 0.75 Cr. 7,468,920 Shares
FaceValue 10
Company Profile

Chennai Meenakshi Multispeciality Hospital Limited (CMMH), formerly known as Devaki Hospital was incorporated on May 13, 1992.

It is a 100-bedded hospital located in the heart of Chennai at Mylapore , it is headed by its CEO, Dr.V.Krishnamurthy, an eminent Rheumatologist. He is ably assisted by a team of dedicated specialists whose USP is commitment, empathy, professional skill, expeditious response and quality care at affordable cost.

Its Services:

The hospital has following specialists :

  • Cardiologist
  • Cosmetic  and Plastic Surgeon
  • Diabetologist
  • Diabetologist and Endocrinologist
  • Dermatologist
  • Dentist
  • ENT
  • Gastro Surgeon
  • General Surgeon
  • Gynecologist
  • General Medicine
  • Vascular Surgeon
  • Minimal  Ascess generalGeneral and  Metabolic  Tumours Surgeon
  • Neurologist
  • Neuro Surgeon
  • Orthopaedics
  • Paediatrician
  • Paediatrition and gastro Entrologist
  • Opthalmology

Its departments:

1) Cardiology Department: There are the following facilities for non-invasive evaluation of cardiac patients

ECG machine

Echocardiography machine (Aloka) SSD 4000

Treadmill machine (Schillers)

Essential evaluation is carried out by cardiologists on a daily basis.

2) Casualty Department 

There is a casualty Department which is manned 24 hours with a Duty doctor and Paramedical team. Emergencies and trauma of all kinds are attended to. Specialist’s services are sought for wherever the needs arises. Trauma and accident care receives special attention round the clock.

3) Diagnostic Services:

Laboratory: There is a well equipped modern laboratory functional round-the-clock and manned by an efficient staff.

 C.T.SCAN and X-Ray machine: A state-of-art CT scan is available for various diagnostic purposes and manned 24 hours for any emergency services. 24 hours x-ray services are also available.

Ultrasound machine/Echocardiography: The Aloka system, a modern and state-of-art machine is used to perform ultrasound evaluation and echocardiography; the procedures are done by specialists in the field.

TreaMill machine: The latest version of Schillers treadmill machine is available for evaluatin I ardiac patients. All tests are only done by the cardiologist.

4)  Intensive Care Unit:

There is a well equipped 12-bedded IMCU I ICCU which is manned 24 hours by efficient, well-trained staff and duty' doctors. There are state-of-art bedside monitors, ventilators, CPAP machines, defibrillators and other supportive equipments ( syringe pumps, diginfusers, nebulizers,' central oxygen and central suctioning) for handling all forms of medical and cardiac emergencies.

5) Nephrology Department6) Physiotherapy Department

 

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+3.34%
1 Week
-4.25%
1 Month
+7.52%
3 Month
+5.23%
6 Month
+11.21%
1 Year
-9.59%
2 Year
+165.80%
5 Year
-11.40%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%)
Return on Capital Employed (%) 18.05 25.90 22.68 5.53 28.38 4.43 39.57 17.45 24.20
Return on Assets (%) 0.47 4.22 2.45 -5.12 3.52 -5.75 7.95 0.25 2.84

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds -6 -5 -5 -5 -5 -6 -4 -4 -4
Non Curr. Liab. 14 13 13 12 12 12 12 12 12
Curr. Liab. 7 9 11 12 11 12 12 11 11
Minority Int.
Equity & Liab. 15 17 19 19 18 18 19 19 19
Non Curr. Assets 13 14 16 16 15 14 15 14 14
Curr. Assets 2 3 3 3 4 4 5 5 5
Misc. Exp. not W/O
Total Assets 15 17 19 19 18 18 19 19 19

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 15 16 18 19 21 19 23 22 26
Other Income 0 0 0 0 0 0 0 1 1
Total Income 15 16 18 19 21 19 24 23 26
Total Expenditure -13 -13 -15 -17 -18 -18 -20 -20 -23
PBIDT 2 3 3 2 3 1 4 3 3
Interest -2 -2 -1 -1 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0
Exceptional Items -1
PAT 0 1 0 -1 1 -1 2 0 1

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 2 5 4 4 2 3 2 2 3
Cash Fr. Inv. -1 -2 -2 -2 0 0 -2 -1 -1
Cash Fr. Finan. -1 -3 -2 -2 -1 -1 -1 -1 -2
Net Change 0 0 0 0 0 1 -1 0 0
Cash & Cash Eqvt 0 0 1 1 1 2 1 1 1

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 55.78 55.78 55.78 55.78 55.78 55.78 55.78 55.78 55.78
Public 44.22 44.22 44.22 44.22 44.22 44.22 44.22 44.22 44.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 02 Aug 2021
Board Meeting Intimation for To Approve Unaudited Quarterly Results For The Quarter Ended 30Th June 2021 And Other Matters
CHENNAI MEENAKSHI MULTISPECIALITY HOSPITAL LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 inter alia to consider and approve Leave of absence; Confirmation of the minutes of the previous Board Meeting held on 28.06.2021;
Register of Contracts; Approval / Review of Related Party Transactions;Taking on record the Minutes of the meeting of Audit Committee & Other Committees;Taking on record the details of share transfers/Demat/Remat of Shares;Review of performance of the company and approval of Unaudited
Statement of Financial results for the Quarter Ended 30.06.2021 and the Limited Review Report of the auditors of the company; Taking on record the Reconciliation of Share Capital Audit Report Shareholding Pattern and Investor Grievance Report for the Quarter Ended 30.06.2021; Review of Compliance Report pertaining to all laws applicable to the Company; Appointment of Scrutinizer for E-Voting in the AGM 2021; Review of consequences of COVID19 and related matters;Taking on record the MOUs entered during the quarter ; Any other matter with the permission of the Chairman.
Fri, 16 Jul 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
We send herewith a copies of the newspaper cuttings in which the Audited Financial Results for the Quarter and Year Ended 31.03.2021 were published (Financial Express-English and Makkal Kural-Tamil).
Fri, 16 Jul 2021
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
We wish to inform that our Share Transfer Registrars M/s. Cameo Corporate Services Limited Chennai -600 002 in their email dated 16.07.2021 informed that the following person has lost his share certificate for 100 equity shares each of Rs.10 each and requested to issue duplicate share certificates.
Name of sh. holder:
MUKTA SATANI JAYANTILAL SATANI (Joint Holder)
Folio: 00019265 Cert.No.2827
Dist. No.: from 1570901 to 1571000 No of shares :100
Letter received on:16.07.2021.






Technical Scans View Details

Wed, 04 Aug 2021
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,527.75 785.85 +0.0%
Divi's Laboratories Ltd. 131,785.24 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,333.82 4,783.30 +0.2%
Cipla Ltd. 75,796.16 945.20 +0.6%
Cadila Healthcare Ltd. 60,170.47 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. 58,468.59 4,075.50 +0.2%
Piramal Enterprises Ltd. 57,915.28 2,601.15 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.40 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 66.41 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.66 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.52 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.20 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 388.86 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 43.47 2,601.15 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.18 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.44 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.15 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.63 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.72 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 1.69 2,601.15 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 19.30 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 25.36 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2020-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%